189 related articles for article (PubMed ID: 27022405)
1. Modeling the Treatment of Glioblastoma Multiforme and Cancer Stem Cells with Ordinary Differential Equations.
Abernathy K; Burke J
Comput Math Methods Med; 2016; 2016():1239861. PubMed ID: 27022405
[TBL] [Abstract][Full Text] [Related]
2. Targeting glioblastoma cancer stem cells: the next great hope?
Khan IS; Ehtesham M
Neurosurg Focus; 2014 Dec; 37(6):E7. PubMed ID: 25581936
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer stem cells for treatment of glioblastoma multiforme.
Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH
Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells in glioblastoma.
Lathia JD; Mack SC; Mulkearns-Hubert EE; Valentim CL; Rich JN
Genes Dev; 2015 Jun; 29(12):1203-17. PubMed ID: 26109046
[TBL] [Abstract][Full Text] [Related]
5. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance.
Yu VY; Nguyen D; Pajonk F; Kupelian P; Kaprealian T; Selch M; Low DA; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):866-75. PubMed ID: 25752402
[TBL] [Abstract][Full Text] [Related]
6. Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.
Fatoo A; Nanaszko MJ; Allen BB; Mok CL; Bukanova EN; Beyene R; Moliterno JA; Boockvar JA
J Neurooncol; 2011 Jul; 103(3):397-408. PubMed ID: 20853017
[TBL] [Abstract][Full Text] [Related]
7. BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma.
Sachdeva R; Wu M; Johnson K; Kim H; Celebre A; Shahzad U; Graham MS; Kessler JA; Chuang JH; Karamchandani J; Bredel M; Verhaak R; Das S
Sci Rep; 2019 Oct; 9(1):14569. PubMed ID: 31602000
[TBL] [Abstract][Full Text] [Related]
8. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
[TBL] [Abstract][Full Text] [Related]
9. Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme.
Borovski T; Beke P; van Tellingen O; Rodermond HM; Verhoeff JJ; Lascano V; Daalhuisen JB; Medema JP; Sprick MR
Oncogene; 2013 Mar; 32(12):1539-48. PubMed ID: 22614016
[TBL] [Abstract][Full Text] [Related]
10. Frontiers in targeting glioma stem cells.
Frosina G
Eur J Cancer; 2011 Mar; 47(4):496-507. PubMed ID: 21185169
[TBL] [Abstract][Full Text] [Related]
11. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
[TBL] [Abstract][Full Text] [Related]
12. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
Eder K; Kalman B
Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
[TBL] [Abstract][Full Text] [Related]
13. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
[TBL] [Abstract][Full Text] [Related]
14. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
15. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A
Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor stem cells and glioblastoma: A review.
van Schaijik B; Wickremesekera AC; Mantamadiotis T; Kaye AH; Tan ST; Stylli SS; Itinteang T
J Clin Neurosci; 2019 Mar; 61():5-9. PubMed ID: 30622004
[TBL] [Abstract][Full Text] [Related]
17. Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesis.
Kast RE; Belda-Iniesta C
Curr Stem Cell Res Ther; 2009 Dec; 4(4):314-7. PubMed ID: 19500061
[TBL] [Abstract][Full Text] [Related]
18. The evolving landscape of glioblastoma stem cells.
Yan K; Yang K; Rich JN
Curr Opin Neurol; 2013 Dec; 26(6):701-7. PubMed ID: 24152818
[TBL] [Abstract][Full Text] [Related]
19. Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.
Lee J; Troike K; Fodor R; Lathia JD
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35023543
[TBL] [Abstract][Full Text] [Related]
20. [Progress in the study of brain tumor stem cells as treatment targets].
Hide T; Kuratsu J
Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
